
WHO approves GLP-1 drugs for weight loss for the first time
For the first time, the WHO has issued guidelines on the use of GLP-1 drugs for treating obesity, highlighting their effectiveness but also emphasizing their high cost and the need for a comprehensive approach. Experts caution about the lack of long-term studies and stress the importance of prevention.
0 —
